What is the treatment for epididymitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Epididymitis

For epididymitis, the treatment regimen should be based on the patient's age and likely causative organisms, with ceftriaxone plus doxycycline for sexually transmitted causes in younger men, and fluoroquinolones for enteric organisms in older men. 1

Diagnostic Approach

Before initiating treatment, proper diagnosis is essential:

  • Unilateral testicular pain and tenderness with palpable swelling of the epididymis
  • Differentiate from testicular torsion (surgical emergency) which presents with:
    • Sudden onset of severe pain
    • High-riding testis
    • Absent cremasteric reflex
    • More common in adolescents

Diagnostic tests should include:

  • Gram-stained smear of urethral exudate
  • Culture or nucleic acid amplification test for N. gonorrhoeae and C. trachomatis
  • Examination of first-void urine for leukocytes
  • Syphilis serology and HIV counseling/testing

Treatment Algorithm Based on Age and Risk Factors

For men under 35 years (likely STI-related):

  • Ceftriaxone 250 mg IM in a single dose PLUS
  • Doxycycline 100 mg orally twice daily for 10 days 1, 2

For men over 35 years OR with enteric organism risk factors:

  • Ofloxacin 300 mg orally twice daily for 10 days OR
  • Levofloxacin 500 mg orally once daily for 10 days 1

For men who practice insertive anal intercourse:

  • Ceftriaxone 250 mg IM in a single dose PLUS
  • Levofloxacin 500 mg orally once daily for 10 days OR Ofloxacin 300 mg orally twice daily for 10 days 3

For patients allergic to cephalosporins and/or tetracyclines:

  • Ofloxacin 300 mg orally twice daily for 10 days OR
  • Levofloxacin 500 mg orally once daily for 10 days 1

Supportive Measures

  • Bed rest
  • Scrotal elevation
  • Analgesics
  • Continue until fever and local inflammation have subsided 1

Follow-Up Considerations

  • Reevaluate if no improvement within 3 days
  • Persistent swelling or tenderness after completing antibiotics requires comprehensive evaluation
  • Consider alternative diagnoses: tumor, abscess, infarction, testicular cancer, TB, or fungal epididymitis 1

Management of Sex Partners

  • For STI-related epididymitis, refer sex partners for evaluation and treatment
  • Partners should be referred if contact occurred within 60 days preceding symptom onset
  • Avoid sexual intercourse until therapy is completed and symptoms have resolved 1

Special Considerations

Immunocompromised Patients

  • HIV-infected patients with uncomplicated epididymitis should receive the same treatment as HIV-negative patients
  • Be aware that fungi and mycobacteria are more likely causes in immunosuppressed patients 1, 4

Rising Antimicrobial Resistance

  • Increasing fluoroquinolone resistance in enteric organisms may necessitate alternative treatments in some regions 5
  • Consider local resistance patterns when selecting antibiotics

Common Pitfalls to Avoid

  1. Misdiagnosing testicular torsion (surgical emergency) as epididymitis
  2. Failing to test for both STIs and urinary pathogens
  3. Not addressing underlying causes (e.g., urinary tract abnormalities, prostatic hyperplasia)
  4. Inadequate follow-up for patients not responding to initial therapy
  5. Neglecting to treat sexual partners in STI-related cases

Early and appropriate treatment is vital to prevent complications such as infertility, chronic scrotal pain, and abscess formation 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epididymitis: An Overview.

American family physician, 2016

Research

Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.